| Drug Name |
Fludarabine |
| Drug ID |
BADD_D00914 |
| Description |
Fludarabine is a chemotherapeutic agent used in the treatment of hematological malignancies. It is commonly marketed under the brand name Fludara. |
| Indications and Usage |
For the treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent containing regimen |
| Marketing Status |
Not Available |
| ATC Code |
L01BB05 |
| DrugBank ID |
DB01073
|
| KEGG ID |
D07966
|
| MeSH ID |
C024352
|
| PubChem ID |
657237
|
| TTD Drug ID |
D0F2XQ
|
| NDC Product Code |
Not Available |
| Synonyms |
fludarabine | 9H-purin-6-amine, 9-beta-D-arabinofuranosyl-2-fluoro- | F-ara-A | 2-fluoroadenine arabinoside | 9-beta-D-arabinofuranosyl-2-fluoroadenine |
